FDA Investigator: Kent A. Conforti
- Kent A. Conforti first started conducting FDA inspections in 2007, with the last inspection in 2024. Over that time, Kent A. Conforti has conducted 254 inspections at 229 companies across 224 sites.
Documents
FDA 483 Andrew C. Siesennop, MD, Boston | August 2023
Available - $199
Kent A. Conforti
Biologics Form 483
FDA 483 Maryellen Fitzgerald, M.D, Watertown | March 2023
Available - $199
Kent A. Conforti
Human Drugs Form 483
FDA 483 Francine M. Foss, New Haven | February 2023
Available - $199
Kent A. Conforti
Human Drugs Form 483
FDA 483 Elizabeth I. Buchbinder, M.D, Boston | October 2022
Available - $199
Kent A. Conforti
Human Drugs Form 483
FDA 483 Douglas Terp, Waterville | June 2021
Available - $199
Kent A. Conforti
Medical Devices & Rad Health Form 483
FDA 483 Monica E. Kleinman, M.D, Boston | August 2020
Available - $199
Kent A. Conforti
Human Drug Form 483
FDA 483 Wayne G. Shreffler, M.D, Boston | January 2020
Available - $199
Kent A. Conforti
Biologic Form 483
FDA 483 David L. Diuguid, M.D, New York | August 2019
Available - $199
Kent A. Conforti
Human Drug Form 483
FDA 483 Maria Alora Palli, M.D, Boston | April 2019
Available - $199
Kent A. Conforti
Human Drug Form 483
FDA 483 Sarepta Therapeutics, Cambridge | April 2018
Available - $199
Kent A. Conforti
Human Drug Form 483
FDA 483 Jane Metrik, Ph.D, Providence | February 2018
Available - $199
Kent A. Conforti
Human Drug Form 483
FDA 483 Jacob M. Sands, M.D., Boston | 2024
Out-of-stock
Kent A. Conforti
Human Drugs Form 483
FDA 483 GE Healthcare Inc. Life Sciences, Marlborough | 2024
Out-of-stock
Kent A. Conforti
Human Drugs Form 483
FDA 483 Jennifer L. Crombie, M.D., Boston | 2023
Out-of-stock
Kent A. Conforti
Human Drugs Form 483
FDA 483 Lumicell, Inc., Newton | 2023
Out-of-stock
Kent A. Conforti
Medical Devices & Rad Health Form 483
FDA 483 Aldeyra Therapeutics, Inc., Lexington | 2023
Out-of-stock
Kent A. Conforti
Human Drugs Form 483
FDA 483 Nezabravka Petrova Haytova, Vratsa | 2022
Out-of-stock
Kent A. Conforti
Human Drugs Form 483
Co-Investigators (44)
- Meredith L. Miller, FDA Investigator
- Richard W. Berning, FDA Investigator
- Scott N. Lim, FDA Investigator
- Tyanna N. Hadley, FDA Investigator
- Jose A. Torres, FDA Investigator
- Michael Serrano, FDA Investigator
- Matthew C. Watson, FDA Investigator
- Alissa E. Berryman, FDA Investigator
- Cheryl A. Grandinetti, FDA Investigator
- Aisha P. Johnson, FDA Investigator
- John L. Zaccone, FDA Investigator
- Jennifer C. Adams, FDA Investigator
- Michael P. Anthony, FDA Investigator
- Michelle S. Anantha, FDA Investigator
- Victoria M. Daddeo, FDA Investigator
- Angela Shepas, FDA Investigator
- Justina O. Tam, FDA Investigator
- Anthony W. Thomas, FDA Investigator
- Karen M. Kondas, FDA Investigator
- Jonathan B. Lewis, FDA Investigator
- Michelle M. Noe Varga, FDA Investigator
- Michelle M. Noe, FDA Investigator
- Noe Varga, Michelle M, FDA Investigator
- Jamie S. Mathews, FDA Investigator
- Alan R. Condon, FDA Investigator
- Ashley M. Whitehurst, FDA Investigator
- Rory Geyer, FDA Investigator
- Lorayne A. McGuinness, FDA Investigator
- Dawn M. Braswell, FDA Investigator
- Mark K. Tseng, FDA Investigator
- Alice C. Silva, FDA Investigator
- Anthony N. Onianwa, FDA Investigator
- Pamela L. Ogonowski, FDA Investigator
- Sherry M. Nisson, FDA Investigator
- Ellen P. Madigan, FDA Investigator
- Bradley D. Newsad, FDA Investigator
- Nichole B. Murphy, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Louis Christy, FDA Investigator
- Jessica D. Spellman, FDA Investigator
- Sylvia A. Craven, FDA Investigator
- Richard F. Hapke, FDA Investigator
- Martin J. Guardia, FDA Investigator